Medical management of thyroid cancer: a risk adapted approach
- 15 June 2008
- journal article
- review article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 97 (8) , 712-716
- https://doi.org/10.1002/jso.21010
Abstract
Risk adapted treatment recommendations are dependent on accurate predictions of the risk of recurrence, risk of death, and likely sites of recurrence. When combined with response to therapy assessments and secondary risk stratification during follow-up, this risk adapted approach will allow the clinician to tailor the aggressiveness of therapy and follow up to the risk of recurrence and death in individual patients.Keywords
This publication has 13 references indexed in Scilit:
- Papillary Thyroid Cancer: Monitoring and TherapyEndocrinology and Metabolism Clinics of North America, 2007
- European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epitheliumActa Endocrinologica, 2006
- Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines TaskforceThyroid®, 2006
- The British Thyroid Association guidelines for the management of thyroid cancer in adultsNuclear Medicine Communications, 2004
- A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up periodSurgery, 2004
- AACE/AAES MEDICAL/SURGICAL Guidelines for Clinical Practice: Management of Thyroid CarcinomaEndocrine Practice, 2001
- Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996Cancer, 2000
- Prospective multicenter study of thyroid carcinoma treatmentCancer, 1998
- Prognostic factors and risk group analysis in follicular carcinoma of the thyroidSurgery, 1995
- A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. thyroid cancer cooperative groupPublished by Elsevier ,1979